TRONDHEIM, Norway--(BUSINESS WIRE)--CardioMech AS announced today that it has appointed Richard Nehm as President and CEO, and Mark Novotny as Chairman of the Board of Directors, effective immediately ...

OSLO, Norway--(BUSINESS WIRE)--CardioMech AS, a privately held company developing a transcatheter mitral valve repair technology, today announced it has expanded its leadership team with the election ...

The Series A, led by a non-disclosed strategic investor, together with Hadean Ventures and Investinor, will fund CardioMech's journey to treat patients in a first-in-human feasibility trial ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

(MENAFN- PR Newswire) CardioMech received strong support by investors despite challenging environment because of its potential to be a category-defining Chordal Repair technology MINNEAPOLIS, Jan. 2, ...

Mitral regurgitation, the backward flow of blood from the left ventricle into the left atrium, is the third most common cardiovascular disease in the United States, Rick Nehm, CEO of CardioMech, said ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min CardioMech is developing a heart ...

MINNEAPOLIS, June 24, 2026 /PRNewswire/ -- Norway-based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology in Fridley, MN ...

CardioMech Strengthens Leadership Team to Advance Development of its Catheter based Minimally Invasive Mitral Valve Repair Technology (TMVr) MINNEAPOLIS, June 24, 2026 /PRNewswire/ -- Norway-based ...